Yanxia Ma

430 total citations
25 papers, 297 citations indexed

About

Yanxia Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanxia Ma has authored 25 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Yanxia Ma's work include Radiopharmaceutical Chemistry and Applications (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer Cells and Metastasis (2 papers). Yanxia Ma is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer Cells and Metastasis (2 papers). Yanxia Ma collaborates with scholars based in China, United States and Canada. Yanxia Ma's co-authors include Abhijit Mazumdar, Powel H. Brown, Lakshmi Reddy Bollu, Dekuang Zhao, Takako Maruyama, Jamal Hill, Shin’ichi Takeda, Yiquan Ke, Noriaki Shimizu and Günther Schütz and has published in prestigious journals such as Nature Communications, Cancer Research and Sustainability.

In The Last Decade

Yanxia Ma

20 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanxia Ma China 9 182 63 49 35 30 25 297
Harini Srinivasan United States 8 155 0.9× 31 0.5× 38 0.8× 34 1.0× 20 0.7× 14 270
Shuai Guo China 9 169 0.9× 51 0.8× 29 0.6× 30 0.9× 20 0.7× 17 294
Tatiana Konovalova Germany 9 236 1.3× 68 1.1× 39 0.8× 30 0.9× 27 0.9× 12 353
Luguo Sun China 12 228 1.3× 43 0.7× 39 0.8× 42 1.2× 25 0.8× 16 372
Yanbin Zheng United States 12 236 1.3× 49 0.8× 64 1.3× 59 1.7× 41 1.4× 23 369
Falin Qu China 14 260 1.4× 140 2.2× 83 1.7× 45 1.3× 33 1.1× 18 439
Kevin T. Bauerle United States 10 171 0.9× 56 0.9× 32 0.7× 42 1.2× 19 0.6× 10 305
Lingfeng Tong China 6 145 0.8× 90 1.4× 32 0.7× 31 0.9× 21 0.7× 11 229
Valeria Simonelli Italy 10 217 1.2× 62 1.0× 74 1.5× 35 1.0× 22 0.7× 15 357
Xiao Ping Zhu China 11 183 1.0× 58 0.9× 45 0.9× 32 0.9× 19 0.6× 18 330

Countries citing papers authored by Yanxia Ma

Since Specialization
Citations

This map shows the geographic impact of Yanxia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Ma more than expected).

Fields of papers citing papers by Yanxia Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Ma. The network helps show where Yanxia Ma may publish in the future.

Co-authorship network of co-authors of Yanxia Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxia Ma. A scholar is included among the top collaborators of Yanxia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxia Ma. Yanxia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Jing, Yanxia Ma, Jamal Hill, et al.. (2024). The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Research. 26(1). 23–23. 5 indexed citations
2.
Ma, Yanxia, Sanjay K. Singh, Duncan H. Mak, et al.. (2024). EPCO-07. INTEGRATING SPATIALLY RESOLVED MULTI-OMICS DATA TO UNCOVER DYSFUNCTIONAL METABOLISM DRIVEN NETWORKS THAT ENHANCE INFILTRATION OF DIFFUSE GLIOMAS. Neuro-Oncology. 26(Supplement_8). viii2–viii2. 1 indexed citations
3.
Ye, Yu, Jintao Wu, Yanxia Ma, et al.. (2023). Phosphoserine-loaded chitosan membranes promote bone regeneration by activating endogenous stem cells. Frontiers in Bioengineering and Biotechnology. 11. 1096532–1096532. 2 indexed citations
4.
Chen, Yongsheng, Huihui Chai, Zhenzhen Li, et al.. (2023). Gut microbiota and their metabolite profiles following peripheral nerve xenotransplantation. Heliyon. 9(8). e18529–e18529. 1 indexed citations
6.
Qian, Jing, Reid T. Powell, Yanxia Ma, et al.. (2022). Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative breast cancer cells. Cancer Research. 82(4_Supplement). GS1–9. 4 indexed citations
7.
Ma, Yanxia, et al.. (2021). Abstract 2411: CEACAM1 is a Critical SOX9-regulated gene that suppresses TNBC growth. Cancer Research. 81(13_Supplement). 2411–2411.
8.
Ma, Yanxia, Jonathan P. Shepherd, Dekuang Zhao, et al.. (2020). SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis. Molecular Cancer Research. 18(12). 1825–1838. 51 indexed citations
9.
Ma, Yanxia, et al.. (2020). Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors. Bioorganic Chemistry. 104. 104356–104356. 17 indexed citations
11.
Bollu, Lakshmi Reddy, Jonathan H. Shepherd, Dekuang Zhao, et al.. (2020). Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1. npj Breast Cancer. 6(1). 2–2. 18 indexed citations
12.
Ma, Yanxia, Jing Qian, Jamal Hill, et al.. (2020). Abstract 1303: PRTN3, RGCC and SLCO4C1 are critical SOX9-regulated genes that control TNBC growth. Cancer Research. 80(16_Supplement). 1303–1303. 1 indexed citations
13.
Ma, Yanxia, Jonathan H. Shepherd, Dekuang Zhao, et al.. (2018). Abstract 3347: SOX9 is a critical regulator of triple-negative breast cancer growth and invasion. Cancer Research. 78(13_Supplement). 3347–3347. 1 indexed citations
14.
Ma, Yanxia, et al.. (2017). Rosemary Extracts Upregulate Nrf2, Sestrin2, and MRP2 Protein Level in Human Hepatoma HepG2 Cells. Evidence-based Complementary and Alternative Medicine. 2017(1). 7359806–7359806. 11 indexed citations
15.
Zhang, Jianping, et al.. (2017). Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells. Oncology Letters. 14(3). 2947–2953. 16 indexed citations
16.
Shimizu, Noriaki, Takako Maruyama, Noritada Yoshikawa, et al.. (2015). A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling. Nature Communications. 6(1). 6693–6693. 101 indexed citations
17.
Shen, Jiandong, Desheng Liang, Zhongmin Zhou, et al.. (2010). Pallister-Killian syndrome: meiosis II non-disjunction may be the first step in the formation of isochromosome 12p.. PubMed. 123(23). 3482–5. 10 indexed citations
18.
Ma, Yanxia, et al.. (2009). Expression and Significance of CXCR4 and MMP-2 in Human Ovarian Epithelial Tumors. Zhongliu fangzhi yanjiu. 36(9). 747–749. 1 indexed citations
19.
Li, Min, et al.. (2008). In vitro anticancer property of a novel thalidomide analogue through inhibition of NF-κB activation in HL-60 cells. Acta Pharmacologica Sinica. 30(1). 134–140. 8 indexed citations
20.
Ma, Yanxia, et al.. (2006). An anticancer effect of a new saponin component from Gymnocladus chinensis Baillon through inactivation of nuclear factor-κB. Anti-Cancer Drugs. 18(1). 41–46. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026